Maia Biotechnology Inc

MAIA12 Dec 2024
Healthcare
$2.16
-0.02 (-2.31%)
Lowest Today
$2.13
Highest Today
$2.17
Today’s Open
$2.16
Prev. Close
$2.16
52 Week High
$5.99
52 Week Low
$0.83
To Invest in Maia Biotechnology Inc

Maia Biotechnology Inc

Healthcare
MAIA12 Dec 2024
-0.02 (-2.31%)
1M
3M
6M
1Y
5Y
Low
$2.13
Day’s Range
High
$2.17
2.13
52 Week Low
$0.83
52-Week Range
52 Week High
$5.99
0.83
1 Day
-
1 Week
+8.79%
1 month return
-17.68%
3 month return
-31.26%
6 month return
-43.76%
1 Year return
+158.69%
3 Years return
-
5 Years return
-
10 Years return
-

Market Status

Fundamentals
Market Cap
54.46 mln
PB Ratio
32.55
PE Ratio
0
Enterprise Value
44 mln
Total Assets
7.57 mln
Volume

Company Financials

Fund house & investment objective

Company Information
MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Organisation
Maia Biotechnology Inc
Employees
13
Industry
Biotechnology
CEO
Dr. Vlad  Vitoc M.B.A., M.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step